SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-076474
Filing Date
2016-01-21
Accepted
2016-01-21 14:44:20
Documents
1
Period of Report
2016-01-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v429400_4.html 4  
1 OWNERSHIP DOCUMENT v429400_4.xml 4 7545
  Complete submission text file 0001144204-16-076474.txt   9067
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3RD FL, BOROUGH A, BLOCK A NO. 181 SOUTH TAIBAI ROAD XI'AN, SHAANXI PROVINCE F4 710065
Business Address
Ren Ken (Reporting) CIK: 0001490733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 161353284